Replies to post #1929 on Vascular Biogenics Ltd (VBLT)

[sys483]

Hey Oren, how about we run a GBM Phase 3 trial with three arms:

Arm 1 - VB-111 monotherapy
Arm 2 - VB-111 injected directly into tumors
Arm 3 - Avastin monotherapy (placebo HaHa)

Do you think we might get better results?